Logo image of CBIT.CA

CATHEDRA BITCOIN INC (CBIT.CA) Stock Fundamental Analysis

TSX-V:CBIT - TSX Venture Exchange - CA14919F2061 - Common Stock - Currency: CAD

0.055  0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CBIT. CBIT was compared to 66 industry peers in the Software industry. CBIT may be in some trouble as it scores bad on both profitability and health. CBIT is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CBIT had positive earnings in the past year.
In the past year CBIT has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: CBIT reported negative net income in multiple years.
CBIT had negative operating cash flow in 4 of the past 5 years.
CBIT.CA Yearly Net Income VS EBIT VS OCF VS FCFCBIT.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 -10M -20M -30M -40M

1.2 Ratios

CBIT's Return On Assets of 4.13% is fine compared to the rest of the industry. CBIT outperforms 70.15% of its industry peers.
CBIT's Return On Equity of 7.35% is fine compared to the rest of the industry. CBIT outperforms 73.13% of its industry peers.
With a decent Return On Invested Capital value of 0.70%, CBIT is doing good in the industry, outperforming 62.69% of the companies in the same industry.
Industry RankSector Rank
ROA 4.13%
ROE 7.35%
ROIC 0.7%
ROA(3y)-67.49%
ROA(5y)-36.43%
ROE(3y)-333.11%
ROE(5y)-195.49%
ROIC(3y)N/A
ROIC(5y)N/A
CBIT.CA Yearly ROA, ROE, ROICCBIT.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600 -800

1.3 Margins

The Profit Margin of CBIT (8.10%) is better than 79.10% of its industry peers.
CBIT's Operating Margin of 1.61% is fine compared to the rest of the industry. CBIT outperforms 61.19% of its industry peers.
CBIT has a Gross Margin of 14.93%. This is in the lower half of the industry: CBIT underperforms 68.66% of its industry peers.
Industry RankSector Rank
OM 1.61%
PM (TTM) 8.1%
GM 14.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CBIT.CA Yearly Profit, Operating, Gross MarginsCBIT.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 200 -200 400 -400

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CBIT is destroying value.
CBIT has more shares outstanding than it did 1 year ago.
CBIT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CBIT has been reduced compared to a year ago.
CBIT.CA Yearly Shares OutstandingCBIT.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
CBIT.CA Yearly Total Debt VS Total AssetsCBIT.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of 0.92, we must say that CBIT is in the distress zone and has some risk of bankruptcy.
CBIT's Altman-Z score of 0.92 is in line compared to the rest of the industry. CBIT outperforms 49.25% of its industry peers.
A Debt/Equity ratio of 0.22 indicates that CBIT is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.22, CBIT is in line with its industry, outperforming 59.70% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z 0.92
ROIC/WACC0.07
WACC10%
CBIT.CA Yearly LT Debt VS Equity VS FCFCBIT.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M 30M

2.3 Liquidity

A Current Ratio of 1.02 indicates that CBIT should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.02, CBIT is in line with its industry, outperforming 47.76% of the companies in the same industry.
CBIT has a Quick Ratio of 1.02. This is a bad value and indicates that CBIT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.90, CBIT is in line with its industry, outperforming 43.28% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 0.9
CBIT.CA Yearly Current Assets VS Current LiabilitesCBIT.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 103.70% over the past year.
CBIT shows a strong growth in Revenue. In the last year, the Revenue has grown by 165.29%.
The Revenue has been growing by 119.98% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)103.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)165.29%
Revenue growth 3Y119.98%
Revenue growth 5YN/A
Sales Q2Q%112.22%

3.2 Future

CBIT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.42% yearly.
Based on estimates for the next years, CBIT will show a very strong growth in Revenue. The Revenue will grow by 49.51% on average per year.
EPS Next Y100%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year87.25%
Revenue Next 2Y49.51%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CBIT.CA Yearly Revenue VS EstimatesCBIT.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
CBIT.CA Yearly EPS VS EstimatesCBIT.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 -0.05 -0.1 -0.15 -0.2

5

4. Valuation

4.1 Price/Earnings Ratio

CBIT is valuated cheaply with a Price/Earnings ratio of 5.50.
Based on the Price/Earnings ratio, CBIT is valued cheaper than 98.51% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.35, CBIT is valued rather cheaply.
Industry RankSector Rank
PE 5.5
Fwd PE N/A
CBIT.CA Price Earnings VS Forward Price EarningsCBIT.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

94.03% of the companies in the same industry are more expensive than CBIT, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.1
CBIT.CA Per share dataCBIT.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 0.04 0.06 0.08 0.1

4.3 Compensation for Growth

CBIT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CBIT's earnings are expected to grow with 41.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.06
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CBIT!.
Industry RankSector Rank
Dividend Yield N/A

CATHEDRA BITCOIN INC

TSX-V:CBIT (3/7/2025, 7:00:00 PM)

0.055

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)12-04 2024-12-04/bmo
Earnings (Next)03-31 2025-03-31
Inst Owners26.48%
Inst Owner ChangeN/A
Ins Owners4.37%
Ins Owner ChangeN/A
Market Cap13.50M
Analysts45.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)50.5%
Min EPS beat(2)0.99%
Max EPS beat(2)100%
EPS beat(4)4
Avg EPS beat(4)100%
Min EPS beat(4)0.99%
Max EPS beat(4)199.01%
EPS beat(8)7
Avg EPS beat(8)18.68%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)11.88%
Min Revenue beat(2)-1.69%
Max Revenue beat(2)25.45%
Revenue beat(4)3
Avg Revenue beat(4)18.18%
Min Revenue beat(4)-1.69%
Max Revenue beat(4)28.87%
Revenue beat(8)6
Avg Revenue beat(8)27.17%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)100%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)165.22%
Revenue NY rev (1m)0%
Revenue NY rev (3m)66.09%
Valuation
Industry RankSector Rank
PE 5.5
Fwd PE N/A
P/S 0.54
P/FCF N/A
P/OCF N/A
P/B 0.49
P/tB 6.04
EV/EBITDA 3.1
EPS(TTM)0.01
EY18.18%
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.1
BVpS0.11
TBVpS0.01
PEG (NY)0.06
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.13%
ROE 7.35%
ROCE 0.98%
ROIC 0.7%
ROICexc 0.79%
ROICexgc 2.54%
OM 1.61%
PM (TTM) 8.1%
GM 14.93%
FCFM N/A
ROA(3y)-67.49%
ROA(5y)-36.43%
ROE(3y)-333.11%
ROE(5y)-195.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA 1.52
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 0.9
Altman-Z 0.92
F-Score5
WACC10%
ROIC/WACC0.07
Cap/Depr(3y)55.69%
Cap/Depr(5y)N/A
Cap/Sales(3y)16.52%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)103.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y100%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)165.29%
Revenue growth 3Y119.98%
Revenue growth 5YN/A
Sales Q2Q%112.22%
Revenue Next Year87.25%
Revenue Next 2Y49.51%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y104.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y92.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y84.76%
OCF growth 3YN/A
OCF growth 5YN/A